More on Medifast (MED): Q3 beats across the board on strong sales momentum across all units....


More on Medifast (MED): Q3 beats across the board on strong sales momentum across all units. Total sales were up nearly 20% Y/Y, while bottom-line results were boosted by better operating efficiencies and lower expenses. Shares +5.5% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs